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ABSTRACT
Background Measurement of post- exertion oxygen 
saturation has been proposed to assess illness 
severity in suspected COVID-19 infection. We aimed 
to determine the accuracy of post- exertional oxygen 
saturation for predicting adverse outcome in suspected 
COVID-19.
Methods We undertook a substudy of an observational 
cohort study across 70 emergency departments during 
the first wave of the COVID-19 pandemic in the UK. 
We collected data prospectively, using a standardised 
assessment form, and retrospectively, using hospital 
records, from patients with suspected COVID-19, 
and reviewed hospital records at 30 days for adverse 
outcome (death or receiving organ support). Patients 
with post- exertion oxygen saturation recorded were 
selected for this analysis. We constructed receiver- 
operating characteristic curves, calculated diagnostic 
parameters, and developed a multivariable model for 
predicting adverse outcome.
Results We analysed data from 817 patients with 
post- exertion oxygen saturation recorded after excluding 
54 in whom measurement appeared unfeasible. 
The c- statistic for post- exertion change in oxygen 
saturation was 0.589 (95% CI 0.465 to 0.713), and 
the positive and negative likelihood ratios of a 3% or 
more desaturation were, respectively, 1.78 (1.25 to 
2.53) and 0.67 (0.46 to 0.98). Multivariable analysis 
showed that post- exertion oxygen saturation was not a 
significant predictor of adverse outcome when baseline 
clinical assessment was taken into account (p=0.368). 
Secondary analysis excluding patients in whom post- 
exertion measurement appeared inappropriate resulted 
in a c- statistic of 0.699 (0.581 to 0.817), likelihood 
ratios of 1.98 (1.26 to 3.10) and 0.61 (0.35 to 1.07), 
and some evidence of additional prognostic value on 
multivariable analysis (p=0.019).
Conclusions Post- exertion oxygen saturation provides 
modest prognostic information in the assessment of 
selected patients attending the emergency department 
with suspected COVID-19.
Trial registration number ISRCTN Registry 
(ISRCTN56149622) http://www. isrctn. com/ 
ISRCTN28342533.
INTRODUCTION
Guidelines for assessment of suspected COVID-19 
recommend measurement of peripheral oxygen 
saturation to determine the severity of acute respira-
tory infection.1–3 Clinicians have noted that patients 
with suspected COVID-19 and a relatively normal 
oxygen saturation may desaturate after exertion, 
but the clinical importance of this finding is uncer-
tain. If shown to predict adverse outcome, testing 
for post- exertional desaturation could be used to 
identify patients needing hospital admission.
Field walking tests are commonly used to eval-
uate exercise capacity and assess prognosis in 
chronic respiratory diseases.4 The lowest arterial 
oxygen saturation recorded during a 6- minute 
walk test is an important marker of disease severity 
and prognosis.5 The rapid 1- minute sit- to- stand 
test correlates with the 6- minute walk test and 
the severity of lung disease.6 Exertional tests have 
shown desaturation in chronic obstructive lung 
disease,7 8 chronic interstitial lung disease9–11 and 
Pneumocystis carinii pneumonia.12 A modified 
6- minute walk test has been proposed for use in 
suspected COVID-19 infection13 but not yet eval-
uated, to our knowledge. A recent review of rapid 
exercise tests for oxygen desaturation14 identified 
Key messages
What is already known on this subject
 ► Post exertional decrease in oxygen saturation 
can be used to predict prognosis in chronic lung 
diseases.
 ► Post exertional desaturation has been proposed 
as a way of predicting adverse outcome in 
people with suspected COVID-19.
What this study adds
 ► Post- exertion oxygen saturation provides 
modest prognostic information in the 
assessment of selected patients attending 
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a number of studies, as outlined above, but found no published 
studies in COVID-19. The authors suggested that a 3% drop in 
oxygen saturation on exercise was a cause for concern, based on 
evidence from other conditions.
The Pandemic Respiratory Infection Emergency System Triage 
(PRIEST) Study is a multicentre observational cohort study 
designed to develop and evaluate triage methods for patients 
with suspected COVID-19 infection. We added evaluation of 
post- exertion oxygen saturation to the aims of the PRIEST Study 
in response to reports of its use in the assessment of suspected 
COVID-19. Our specific objective for this post hoc substudy was 
to determine the accuracy of post- exertional oxygen saturation 
as a prognostic factor for 30- day adverse outcome.
METHODS
For the PRIEST Study, we collected data from consecutive 
patients presenting with suspected COVID-19 infection to 70 
hospital emergency departments (EDs) from 53 recruiting sites 
in the UK, where some sites cover more than one hospital. 
Hospitals used either prospective data collection, through a stan-
dardised assessment form for suspected COVID-19, or retro-
spective data collection, through research staff extracting data 
from hospital records onto the standardised form.
Patients were included in the PRIEST Study if the assessing 
clinician used the standardised assessment form or recorded 
that the patient had suspected COVID-19 infection. The clin-
ical diagnostic criteria used for suspected COVID-19 during the 
study were1 fever (≥38°C) or a history of fever and2 influenza- 
like illness (two or more of cough, sore throat, rhinorrhoea, limb 
or joint pain, headache, vomiting or diarrhoea) or severe and/
or life- threatening illness suggestive of an infectious process. 
We did not seek consent to collect data but information about 
the study was provided in the ED and patients could withdraw 
their data at their request. Patients with multiple presentations 
to hospital were only included once, using data from the first 
presentation identified by research staff.
The population for this substudy was patients who had post- 
exertion oxygen saturation recorded as part of routine care. The 
assessing clinician made the decision to measure post- exertion 
oxygen saturation and determined the approach to achieving 
exertion. The study did not influence clinical care, so we were 
unable to standardise the selection of patients or the approach to 
measuring post- exertion oxygen saturation. Measurement could 
have been undertaken deliberately, by asking the patient to exer-
cise in a specified way, or opportunistically, by recording oxygen 
saturation after the patient had exerted themselves for another 
purpose.
Research staff reviewed hospital records to identify outcomes 
up to 30 days after initial presentation. We defined patients who 
died or required respiratory, cardiovascular or renal support as 
having an adverse outcome. We defined respiratory support as 
any intervention to protect the patient’s airway or assist their 
ventilation, including mechanical ventilation, non- invasive 
ventilation or continuous positive airway pressure, but not 
supplemental oxygen alone or nebulised bronchodilators. We 
defined cardiovascular support as any intervention to maintain 
organ perfusion, including extracorporeal membrane oxygen-
ation, inotropic drugs or invasive cardiovascular monitoring, but 
not peripheral intravenous cannulation and/or fluid administra-
tion. We defined renal support as any intervention to assist renal 
function, including haemofiltration, haemodialysis or peritoneal 
dialysis, but not intravenous fluid administration or urinary 
catheterisation.
We undertook an initial descriptive analysis of the patients 
with post- exertion oxygen saturation recorded. This identified 
a number of patients for whom post- exertion oxygen satura-
tion measurement appeared unfeasible, based on age (less than 
3 years), performance status bed/chair bound, baseline oxygen 
saturation below 85%, post- exertion oxygen saturation below 
50%, receiving supplemental oxygen or Glasgow Coma Score 
less than 14. We excluded these patients from the analysis.
We examined baseline oxygen saturation, post- exertion 
oxygen saturation and post- exertion change in oxygen saturation 
(ie, baseline minus post- exertion oxygen saturation). Analysis 
focused on the latter, because this indicates the additional value 
achieved by measuring oxygen saturation after exertion. We esti-
mated the accuracy of each index test in terms of the sensitivity, 
specificity and likelihood ratios of each test across a range of 
thresholds for positivity, for predicting adverse outcome up to 30 
days. CIs for likelihood ratios were calculated using the methods 
outlined in Bedrick and Koopman.15 Receiving- operator charac-
teristic (ROC) curves were constructed and the c- statistic (area 
under the ROC curve) was calculated for each index test. We 
did not attempt to determine an optimal threshold for positivity, 
because that depends on the relative importance of sensitivity 
and specificity in the decision that post- exertion oxygen satu-
ration is intended to inform. However, we decided a priori to 
highlight the performance of a 3% desaturation, as suggested 
by Greenhalgh et al.14 Analysis was performed on patients with 
post- exertion oxygen saturation recorded and available 30- day 
outcome data, as such missing data were not imputed.
To determine whether measurement of post- exertion oxygen 
saturation adds prognostic information to standard respiratory 
assessment, we fitted a multivariable logistic regression model 
with age, baseline oxygen saturation, respiratory rate, heart rate, 
asthma, other chronic respiratory illness and post- exertional 
oxygen saturation as covariates.
We undertook a secondary analysis that excluded patients for 
whom post- exertion oxygen saturation measurement appeared 
less appropriate, based on age (less than 16 years), performance 
status of limited self- care, baseline oxygen saturation less than 
94%, or heart rate, respiratory rate or systolic blood pressure 
scoring 3 points on the National Early Warning Score (NEWS2). 
The rationale for this analysis was that local guidelines3 recom-
mend admission for patients with oxygen saturation less than 
94% or a score of 3 points or more on any NEWS2 parameter. 
It has also been suggested that post- exertional assessment is only 
undertaken in a patient able to stand safely unaided and whose 
resting saturation is 96% or above.14
We planned for the PRIEST Study to recruit a sample size of 
20 000. The analysis presented here is a secondary analysis, so no 
sample size was prespecified.
Patient and public involvement
The Sheffield Emergency Care Forum (SECF) is a public 
representative group interested in emergency care research.16 
Members of SECF advised on the development of the PRIEST 
Study and two members joined the Study Steering Committee. 
Patients were not involved in the recruitment and conduct of 
the study. We are unable to disseminate the findings to study 
participants directly.
RESULTS
The PRIEST Study recruited 22 484 patients across 70 hospi-
tals between 26 March 2020 and 28 May 2020, of whom 39 
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who had post- exertion oxygen saturation recorded and excluded 
57 in whom measurement appeared unfeasible, leaving 817 for 
analysis. Adverse outcome occurred in 30 participants (3.7%), of 
these 9 died, 22 had respiratory support, 5 had cardiovascular 
support and 4 renal support.
Online supplemental figure 1 shows the flow of patients 
through the study, and online supplemental table S1 shows the 
characteristics of the whole PRIEST cohort and the characteris-
tics of those included in this analysis. Participants in this anal-
ysis were younger, more likely to have unrestricted performance 
status, less likely to have any comorbidities, tended to have 
more normal baseline physiology and had a much lower rate of 
adverse outcome.
Table 1 compares the baseline oxygen saturation, post- exertion 
oxygen saturation and post- exertion change between those with 
and without an adverse outcome. Post- exertion oxygen saturation 
tended to be lower than baseline oxygen saturation and showed 
a greater decrease in those who suffered adverse outcome (2.9% 
vs 1.9% mean decrease). However, figure 1 shows that oxygen 
saturations increased post- exertion in a proportion of cases and 
there was considerable overlap between those with and without 
adverse outcome. Online supplemental figures S2 and S3 show 
overlaid histograms for baseline and post- exertion oxygen 
saturation.
Figure 2 shows the ROC curves for baseline oxygen satura-
tion, post- exertion oxygen saturation and post- exertion change 
in oxygen saturation. The c- statistic of 0.589 (95% CI 0.465 
to 0.713) for post- exertion change indicates poor discriminant 
value, that is, post- exertion change does not predict adverse 
outcome. This is partly due to post- exertion increases in oxygen 
saturation showing some association with increased risk of 
adverse outcome. Table 2 reports sensitivity, specificity and like-
lihood ratios for thresholds of post- exertion decrease in oxygen 
saturation (ie, change less than zero). The positive and negative 
likelihood ratios of a post- exertional desaturation of 3% or more 
were 1.78 and 0.67, respectively, suggesting that this finding 
provides a small amount of additional information in prognostic 
assessment. Online supplemental tables S2 and S3 show the diag-
nostic parameters for baseline and post- exertion oxygen satura-
tion, respectively.
Figure 3 and table 3 show comparable results for the secondary 
analysis excluding cases where post- exertion oxygen saturation 
measurement appeared less appropriate. The c- statistic of 0.699 
(95% CI 0.581 to 0.817) for post- exertion change in oxygen 
saturation indicates better discriminant value in this group, that 
is, post- exertion change predicts an increased risk of adverse 
outcome. This may be explained by exclusion of patients with 
lower baseline oxygen saturations who had more potential to 
show a random post- exertion increase in oxygen saturation. 
The positive and negative likelihood ratios of a post- exertional 
decrease in oxygen saturation of 3% or more were 1.98 and 
0.61, respectively, indicating some modest value in predicting 
Table 1 Comparison of index tests summary statistics between those 







  N (%) 30 (100.0) 783 (99.5) 813 (99.5)
  Mean (SD) 94.5 (3.5) 97.1 (2.3) 97.0 (2.4)
  Median (IQR) 95.0 (92.0–97.0) 97.0 (96.0–99.0) 97.0 (96.0–99.0)
Post- exertion oxygen saturation
  N (%) 30 (100.0) 787 (100.0) 817 (100.0)
  Mean (SD) 91.6 (5.3) 95.2 (4.2) 95.0 (4.3)
  Median (IQR) 92.0 (88.0–96.0) 96.0 (93.0–98.0) 96.0 (93.0–98.0)
Oxygen saturation difference, pre- exercise to post- exercise
  N (%) 30 (100.0) 783 (99.5) 813 (99.5)
  Mean (SD) −2.9 (5.3) −1.9 (3.5) −2.0 (3.5)
  Median (IQR) −3.0 (−6.0 to 0.0) −1.0 (−3.0 to 0.0) −1.0 (−3.0 to 0.0)
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adverse outcome. Online supplemental tables S4 and S5 show 
the diagnostic parameters for baseline and post- exertion oxygen 
saturation, respectively, for the secondary analysis.
In the multivariable model on the primary analysis cohort, 
post- exertional oxygen saturation did not add prognostic value 
over other factors in the model (p value for model coefficient 
0.368, likelihood ratio test for model with and without post- 
exertion oxygen saturation 0.78, p=0.376). For the secondary 
analysis, post- exertional oxygen saturation added prognostic 
value over other factors (p value for model coefficient 0.019, 
likelihood ratio test for model with and without post- exertion 
oxygen saturation 4.82, p=0.078), indicating that post- exertion 
desaturation may help to predict adverse outcome even when 
other clinical features are taken into account.
DISCUSSION
Our findings suggest that measurement of post- exertion oxygen 
saturation adds modest prognostic information to clinical assess-
ment of suspected COVID-19 in the ED. The likelihood ratios in 
the primary analysis suggest that a desaturation of 3% or more 
provides a small amount of prognostic information, the c- sta-
tistic of 0.589 for post- exertion change suggests little discrimi-
nant value, and multivariate analysis suggests that post- exertion 
oxygen saturation measurement does not add prognostic value 
once baseline measurements are taken into account. Secondary 
analysis limited to more appropriate cases suggested better 
discriminant value, with a c- statistic of 0.699, and additional 
prognostic value on multivariable analysis. In appropriate cases, 
post- exertion oxygen saturation measurement should be safe 
Figure 2 ROC curves showing index test accuracies for predicting 
adverse outcome, primary analysis (n=817). ROC, receiving- operator 
characteristic.





(95% CI) Positive likelihood ratio (95% CI) Negative likelihood ratio (95% CI)
<=−1 70.0 (50.6 to 85.3) 43.6 (40.0 to 47.1) 1.24 (0.97 to 1.58) 0.69 (0.40 to 1.20)
<=−2 53.3 (34.3 to 71.7) 59.3 (55.7 to 62.7) 1.31 (0.93 to 1.85) 0.79 (0.54 to 1.16)
<=−3 53.3 (34.3 to 71.7) 70.1 (66.8 to 73.3) 1.78 (1.25 to 2.53) 0.67 (0.46 to 0.98)
<=−4 40.0 (22.7 to 59.4) 77.3 (74.2 to 80.2) 1.76 (1.11 to 2.78) 0.78 (0.58 to 1.05)
<=−5 36.7 (19.9 to 56.1) 82.2 (79.4 to 84.9) 2.07 (1.26 to 3.39) 0.77 (0.59 to 1.01)
<=−6 30.0 (14.7 to 49.4) 86.1 (83.5 to 88.4) 2.16 (1.22 to 3.83) 0.81 (0.64 to 1.03)
<=−7 23.3 (9.9 to 42.3) 90.5 (88.3 to 92.5) 2.47 (1.25 to 4.89) 0.85 (0.70 to 1.04)
<=−8 20.0 (7.7 to 38.6) 92.5 (90.4 to 94.2) 2.65 (1.24 to 5.65) 0.87 (0.73 to 1.04)
<=−9 16.7 (5.6 to 34.7) 94.0 (92.1 to 95.6) 2.78 (1.19 to 6.48) 0.89 (0.76 to 1.05)
<=−10 10.0 (2.1 to 26.5) 95.1 (93.4 to 96.5) 2.06 (0.67 to 6.30) 0.95 (0.84 to 1.07)
Figure 3 ROC curves showing index test accuracies for predicting 
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and relatively easy to incorporate into clinical assessment. It may 
therefore be worth using in selected patients, such as those with 
normal baseline observations and oxygen saturation. The low 
risk of adverse outcome in these selected patients means that 
absence of desaturation could provide reassurance that discharge 
home is appropriate.
The observation that oxygen saturation increased post- 
exertion, and that some people with adverse outcome showed 
an increase, may seem surprising, but is probably explained by 
random variation. Oxygen saturation varies randomly from one 
measurement to the next and this variation is likely to be greater 
in sicker patients with baseline hypoxia. Thus, we might expect 
greater variation in oxygen saturation to show some association 
with adverse outcome.
Greenhalgh et al14 suggested using a desaturation of at least 
3% to identify cause for concern in selected patients who are 
well enough for out- of- hospital management. Our findings 
suggest that a 3% desaturation indicates a small increase in the 
likelihood of adverse outcome. Further research could determine 
whether a more systematic and rigorously controlled approach 
to post- exertion oxygen saturation measurement can result in 
more useful prognostic information. The feasibility of such 
research may be limited by low event rates in people who are 
able to undertake formal post- exertion measurement of oxygen 
saturation.
Our study consisted of a clinically relevant population and was 
recruited across a wide range of settings, but evaluation of post- 
exertion oxygen saturation was a post hoc secondary analysis 
and the study was not designed specifically for this purpose. We 
are unable to say how patients were selected for measurement 
of post- exertion oxygen saturation, and the method for under-
taking exertion was not standardised or recorded. We excluded 
57 patients from analysis for whom post- exertion oxygen satu-
ration measurement appeared unfeasible, and excluded a further 
162 from secondary analysis for whom measurement appeared 
less appropriate. These cases may reflect opportunistic oxygen 
saturation measurement after exertion, such as on attempting to 
mobilise, but we cannot exclude the possibility of data recording 
errors. Furthermore, our judgements regarding feasibility and 
appropriateness of measurement were somewhat subjective, so 
others may consider that measurement in these cases could be 
feasible or appropriate. Only 874 out of 22 445 patients (3.9%) 
had post- exertion oxygen saturation recorded. This may reflect 
limited awareness and use of post- exertion oxygen saturation, 
but may also reflect severity of illness in the ED population. 
Measurement of post- exertion oxygen saturation is only likely 
to be feasible and clinically indicated in those with milder illness. 
The relatively small number of adverse outcomes (N=30) limited 
the precision of our estimates of sensitivity and power to under-
take multivariable analysis.
In summary, measuring post- exertion oxygen saturation 
provides modest prognostic information in the assessment of 
selected patients attending the ED with suspected COVID-19. 
It could be added to clinical assessment for patients with normal 
baseline oxygen saturation when there is uncertainty around the 
decision to admit to hospital.
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